Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4019-4027
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4019
Table 3 Patient characteristics: Type of operation and survival data
PatientGenderAge (yr)IncidentalTNM 6th editionCystic ductResectionSurgery5-yr survival
1M63NopT2 N1 MxR0R0Wedge res. (IVb + V) + lymphadenectomy (Istage)Alive, 15 mo
2F82NopT4 N2 M1R0R1Wedge res. (IVb + V) + lymphadenectomy (Istage) + CBD res.Dead, 3 mo
3F60NopT3 N1 MxR1R1Wedge res. (IVb + V) + lymphadenectomy (Istage)Dead, 6 mo
4F72NopT3 N1 MxR0R1Wedge res. (IVb + V) + lymphadenectomy (Istage)Dead, 8 mo
5M76NopT4 N1 MxR0R1Wedge res. (IVb + V) + lymphadenectomy (Istage)Dead, 7 mo
6M81NopT3 N0 MxR0R1Wedge res. (IVb + V) + lymphadenectomy (Istage)Dead, 9 mo
7F77NopT2 N0 MxR0R0Wedge res. (IVb + V) + lymphadenectomy (Istage)Dead, 24 mo
8F45NoPT1a N0 MxR0R0Cholecystectomy, no further surgeryAlive, no recurrence at 5 yr
9F81NoPT3 N1 MxR0R1Wedge res. (IVb + V) + lymphadenectomy (Istage)Dead, 28 mo
10F66NopT1b N0 MxR0R0Wedge res. (IVb + V) + lymphadenectomy (Istage)Alive, no recurrence at 5 yr
11M69YespT1b N0 MxR0R0LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS excAlive, 38 mo (disease recurrence)
12M65YesPT1a Nx MxR0R0CholecystectomyAlive, no recurrence at 6 yr
13F72YespT2 N0 MxR0R0LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS excAlive, no recurrence at 5 yr
14M55YespT2 N0 M1R1R1LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + CBD and PS excDead, 8 mo
15F78YespT2 N1 MxR0R0Cholecystectomy, refused further surgeryDead, 26 mo
16F57YespT1b N0 MxR0R0LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS excAlive, no recurrence at 5 yr
17M71YespT2 N1 MxR0R0LC (stage) - wedge res. (IVb + V) + lymphadenectomy (II stage) + PS excDead, 23 mo
18F61YespTis Nx MxR0R0LCAlive, no recurrence at 5 yr
19M69YespT1b N0 MxR0R0Cholecystectomy, refused further surgeryAlive, no recurrence at 5 yr